Please use this identifier to cite or link to this item: https://doi.org/10.1345/aph.1R408
Title: Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in Asian breast cancer patients
Authors: Cheung, Y.T.
Shwe, M.
Chui, W.K. 
Chay, W.Y.
Ang, S.F.
Dent, R.A.
Yap, Y.S.
Lo, S.K.
Ng, R.C.H.
Chan, A. 
Keywords: Anxiety
Cancer
Chemobrain
Cognitive function
Psycho-oncology
Psychosocial distress
Quality of life
Issue Date: Dec-2012
Citation: Cheung, Y.T., Shwe, M., Chui, W.K., Chay, W.Y., Ang, S.F., Dent, R.A., Yap, Y.S., Lo, S.K., Ng, R.C.H., Chan, A. (2012-12). Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in Asian breast cancer patients. Annals of Pharmacotherapy 46 (12) : 1645-1655. ScholarBank@NUS Repository. https://doi.org/10.1345/aph.1R408
Abstract: BACKGROUND: There is conflicting evidence on the effect of chemotherapy and psychosocial distress on perceived cognitive changes in cancer patients. OBJECTIVE: To compare the severity of perceived cognitive disturbance in Asian breast cancer patients receiving chemotherapy and those not receiving chemotherapy, and identify clinical characteristics associated with perceived cognitive disturbances. METHODS: A cross-sectional, observational study was conducted at the largest cancer center in Singapore. Breast cancer patients receiving chemotherapy and not receiving chemotherapy completed the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog), European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30), and Beck Anxiety Inventory to assess their perceived cognitive functioning, health-related quality of life, and anxiety, respectively. Multiple regression was conducted to delineate the factors associated with perceived cognitive disturbances. RESULTS: A total of 85 breast cancer patients receiving chemotherapy and 81 not receiving chemotherapy were recruited. Chemotherapy patients experienced more fatigue (QLQ-C30 fatigue scores: 33.3 vs 22.2 points; p = 0.005) and moderate-to- severe anxiety (21.9% vs 8.6%; p = 0.002) compared to non-chemotherapy patients. Non-chemotherapy patients reported better perceived cognitive functioning than those who received chemotherapy (FACT-Cog scores: 124 vs 110 points, respectively; p < 0.001). Chemotherapy and endocrine therapy were strongly associated with perceived cognitive disturbances (p < 0.001 and 0.021, respectively). The interacting effect between anxiety and fatigue was moderately associated with perceived cognitive disturbances (β = -0.29; p = 0.037). CONCLUSIONS: Chemotherapy and endocrine treatment were associated with significant cognitive disturbances among Asian breast cancer patients. Psychosocial factors could be used to identify cancer patients who are more susceptible to cognitive disturbances in the clinical setting.
Source Title: Annals of Pharmacotherapy
URI: http://scholarbank.nus.edu.sg/handle/10635/105895
ISSN: 10600280
DOI: 10.1345/aph.1R408
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

15
checked on Sep 19, 2018

WEB OF SCIENCETM
Citations

16
checked on Sep 19, 2018

Page view(s)

69
checked on Aug 23, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.